Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction

Anastasios Lymperopoulos, Giuseppe Rengo, Erhe Gao, Steven N. Ebert, Gerald W. Dorn, Walter J. Koch

Research output: Contribution to journalArticlepeer-review

90 Scopus citations

Fingerprint

Dive into the research topics of 'Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds